Eli Lilly settles Cialis patent litigation with generic makers

18-07-2017

Eli Lilly settles Cialis patent litigation with generic makers

Photo: Courtesy of Eli Lilly

Eli Lilly has entered into a settlement agreement with generic companies Teva Pharmaceuticals and Watson Laboratories to resolve pending patent litigation over its drug Cialis (tadalafil).


Eli Lilly, Cialis, patent, generic, Teva, Watson Laboratories, US District Court for the Eastern District of Virginia

LSIPR